CARCINOMA, NON-SMALL-CELL LUNG

This study is testing if adding an inhaled drug called azacytidine to standard pre-surgery treatment can better shrink early-stage lung cancer tumors. The goal is to find the safest dose of the inhaled drug and see if it helps eliminate more cancer cells before surgery. About 60 …

This study compares two types of lung cancer surgery for patients who have already responded well to immunotherapy. It aims to see if a less extensive surgery, which removes less lung tissue, is as effective at controlling cancer as the standard, more extensive surgery. The goal …

This study is testing a new way to plan radiation therapy for lung cancer. Researchers will use a special type of MRI scan that uses xenon gas to create a detailed 3D map of how well different parts of the lungs are working. The goal is to direct the radiation beams more precisel…

This study aims to see if a new drug called QL2107 behaves the same way in the body as the established cancer drug Keytruda. It will involve 122 adults with non-small cell lung cancer who have had their tumor surgically removed and completed chemotherapy. The main goal is to prov…

This trial is testing if two already-approved cancer drugs, dabrafenib and trametinib, can help patients with rare cancers or common cancers that have a rare, specific genetic change called a BRAF V600 mutation. The drugs are already used for some cancers like melanoma, but resea…

This study is testing an experimental drug called N17350 for adults with advanced solid tumors that have spread or stopped responding to standard treatments. The drug is injected directly into a tumor every two weeks to try to stimulate the immune system to fight the cancer. The …